All in-frame fusions involved genes with unknown oncogenic function by OncoKB, except for a single fusion involving ALDH1L2—a folate regulatory enzyme considered likely oncogenic, but with no established role in lung cancer or neuroendocrine cancers (25). This evidence concerns the gene ALDH1L2 and neuroendocrine carcinoma.